Skip to main content
Premium Trial:

Request an Annual Quote

Flatiron Health, FDA Partner on Cancer Research Project

NEW YORK (GenomeWeb) – Flatiron Health announced today that it has signed a research deal with the US Food and Drug Administration to determine how real-world evidence derived from patient data captured outside of clinical trials can provide insights into the safety and efficacy of new anti-cancer therapies.

"With only four percent of the adult US cancer population enrolled in clinical trials, we as providers are currently limited to making clinical decisions based upon study results that represent only a small number of patients," Flatiron Chief Medical Officer Amy Abernethy said in a statement. "This makes it nearly impossible to estimate whether a treatment will work, anticipate all of the potential side effects of therapies, or even decide which treatment should precede another." 

Under the terms of the deal, Flatiron and the FDA's Center for Drug Evaluation and Research will start by using de-identified, HIPPA-compliant data from patients with advanced non-small cell lung cancer who are receiving immunotherapy to explore analytic approaches, clinically relevant endpoints, and safety assessment methods.

"Collaborative projects such as this one with the FDA allow us to access real-world evidence for more accurate and actionable insights into patient care and expected outcomes outside of clinical trials, supporting the delivery of high quality patient care," Abernethy added.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.